Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gatlan vs Ivy Rx

Gatlan
Graded #389

Lower grade

vs+9
Ivy Rx
Graded #178

Higher grade

The verdict

Ivy Rx takes it — 66.8/100 to 57.8/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +17
45
62
Dose & formulationIvy Rx +24
40
64
Clinical oversightEven
82
82
Labs & monitoringGatlan +9
62
53
FulfillmentIvy Rx +11
70
81
Contract termsEven
55
55
Gatlan · left barIvy Rx · right bar

The numbers

MetricGatlanIvy Rx
WeighScore57.8/10066.8/100
GradeCC
Scorecard rank#389#178
SemaglutideNot disclosed$175/mo (starting dose, compounded)
TirzepatideNot disclosed$275/mo (starting dose, compounded)
Coverage44 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Gatlan

Graded #389 · C

Strengths

  • Named Chief Medical Advisor with verifiable credentials — Dr. Robert Lufkin, UCLA/USC professor — rare in this market
  • 44 states explicitly listed — you can confirm coverage without starting the sign-up flow
  • 'Doctor-Level Care, Minus the Friction' positioning targets buyers wanting premium clinical attention
  • Fully online process with concierge delivery and monitoring
  • Compounded tirzepatide confirmed

Where it loses points

  • Pricing not shown publicly — fully gated behind the sign-up flow
  • Unclear whether compounded semaglutide is offered — only tirzepatide is mentioned on the site
  • LegitScript certification status not disclosed
  • 503A/503B pharmacy partner not named, and designation not specified
  • No compounded-medication disclaimer published
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard